Bull
$53.53
Scenario price
$42.200
+0.578 (+1.37%)At close
KB Home is a homebuilding company, which builds a variety of new homes, including attached and detached single-family residential homes, townhomes and condominiums, designed primarily for first-time and first move-up, as well as second move-up and active adult, homebuyers. It offers homes in development communities, at urban in-fill locations and as part of mixed-use projects. Its segments include homebuilding and financial services. The homebuilding segments is engaged in the acquisition and development of land primarily for residential purposes. The financial services reporting segment offers property and casualty insurance and, in certain instances, earthquakes, flood and personal property insurance to its homebuyers in the same markets as its homebuilding segments and provides title services in the majority of its markets. It offers mortgage banking services, including residential consumer mortgage loan originations, to its homebuyers indirectly through KBHS Home Loans, LLC.
KB Home is not a good buy right now due to its current price of $43.13, which is close to the $43 price target set by Melius Research. The stock has a very low RSI of 19.082, indicating it is oversold, but the negative trend in net income and gross margin, which has dropped to 5.54%, suggests ongoing financial struggles. The main risk is the significant decline in stock performance, with a year-to-date change of -24.43%, indicating a challenging market environment for housing stocks.
Goldman Sachs
$56
2026-10-12
Goldman Sachs
2026-10-12
Price Target
$56
Keefe Bruyette
$54
2026-10-05
Keefe Bruyette
2026-10-05
Price Target
$54
Morgan Stanley
$39
2026-10-01
Morgan Stanley
2026-10-01
Price Target
$39
Truist
$50
2026-09-23
Truist
2026-09-23
Price Target
$50
Evercore ISI
$59
2026-09-23
Evercore ISI
2026-09-23
Price Target
$59
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

KB Home Opens New Communities in California

KB Home Opens New Gated Community Camellia Glen for Tours

KB Home Declares Quarterly Cash Dividend

S&P 500 Hits Record High Amid Market Optimism

Melius Research Optimistic on Housing Market Recovery
KB Home is a homebuilding company, which builds a variety of new homes, including attached and detached single-family residential homes, townhomes and condominiums, designed primarily for first-time and first move-up, as well as second move-up and active adult, homebuyers. It offers homes in development communities, at urban in-fill locations and as part of mixed-use projects. Its segments include homebuilding and financial services. The homebuilding segments is engaged in the acquisition and development of land primarily for residential purposes. The financial services reporting segment offers property and casualty insurance and, in certain instances, earthquakes, flood and personal property insurance to its homebuyers in the same markets as its homebuilding segments and provides title services in the majority of its markets. It offers mortgage banking services, including residential consumer mortgage loan originations, to its homebuyers indirectly through KBHS Home Loans, LLC. It operates in the Consumer Cyclicals sector (OPERATIVE BUILDERS industry).
KB Home is not a good buy right now due to its current price of $43.13, which is close to the $43 price target set by Melius Research. The stock has a very low RSI of 19.082, indicating it is oversold, but the negative trend in net income and gross margin, which has dropped to 5.54%, suggests ongoing financial struggles. The main risk is the significant decline in stock performance, with a year-to-date change of -24.43%, indicating a challenging market environment for housing stocks.
22 analysts cover KBH: 1 rate it Buy, 16 Hold and 5 Sell. The average price target is 58.38.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.